Cabrera T - Search Results

1

Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapy.

Ruiz-Cabello F, Cabrera T, Lopez-Nevot MA, Garrido F. Ruiz-Cabello F, et al. Among authors: cabrera t. Semin Cancer Biol. 2002 Feb;12(1):15-24. doi: 10.1006/scbi.2001.0406. Semin Cancer Biol. 2002. PMID: 11926407 Review.

2

Analysis of HLA expression in human tumor tissues.

Cabrera T, López-Nevot MA, Gaforio JJ, Ruiz-Cabello F, Garrido F. Cabrera T, et al. Cancer Immunol Immunother. 2003 Jan;52(1):1-9. doi: 10.1007/s00262-002-0332-0. Epub 2002 Dec 10. Cancer Immunol Immunother. 2003. PMID: 12536234 Free PMC article. Review.

3

Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.

Romero JM, Jiménez P, Cabrera T, Cózar JM, Pedrinaci S, Tallada M, Garrido F, Ruiz-Cabello F. Romero JM, et al. Among authors: cabrera t. Int J Cancer. 2005 Feb 10;113(4):605-10. doi: 10.1002/ijc.20499. Int J Cancer. 2005. PMID: 15455355

4

HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination.

Cabrera T, Lara E, Romero JM, Maleno I, Real LM, Ruiz-Cabello F, Valero P, Camacho FM, Garrido F. Cabrera T, et al. Cancer Immunol Immunother. 2007 May;56(5):709-17. doi: 10.1007/s00262-006-0226-7. Epub 2006 Sep 8. Cancer Immunol Immunother. 2007. PMID: 16960691 Free PMC article.

5

Role of altered expression of HLA class I molecules in cancer progression.

Aptsiauri N, Cabrera T, Mendez R, Garcia-Lora A, Ruiz-Cabello F, Garrido F. Aptsiauri N, et al. Among authors: cabrera t. Adv Exp Med Biol. 2007;601:123-31. doi: 10.1007/978-0-387-72005-0_13. Adv Exp Med Biol. 2007. PMID: 17712999 Review.

6

Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations.

Aptsiauri N, Carretero R, Garcia-Lora A, Real LM, Cabrera T, Garrido F. Aptsiauri N, et al. Among authors: cabrera t. Cancer Immunol Immunother. 2008 Nov;57(11):1727-33. doi: 10.1007/s00262-008-0532-3. Epub 2008 May 20. Cancer Immunol Immunother. 2008. PMID: 18491093 Free PMC article. Review.

7

Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy.

Carretero R, Romero JM, Ruiz-Cabello F, Maleno I, Rodriguez F, Camacho FM, Real LM, Garrido F, Cabrera T. Carretero R, et al. Among authors: cabrera t. Immunogenetics. 2008 Aug;60(8):439-47. doi: 10.1007/s00251-008-0303-5. Epub 2008 Jun 11. Immunogenetics. 2008. PMID: 18545995

8

"Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy.

Garrido F, Cabrera T, Aptsiauri N. Garrido F, et al. Among authors: cabrera t. Int J Cancer. 2010 Jul 15;127(2):249-56. doi: 10.1002/ijc.25270. Int J Cancer. 2010. PMID: 20178101 Review.

9

Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells.

Carretero R, Cabrera T, Gil H, Saenz-Lopez P, Maleno I, Aptsiauri N, Cozar JM, Garrido F. Carretero R, et al. Among authors: cabrera t. Int J Cancer. 2011 Aug 15;129(4):839-46. doi: 10.1002/ijc.25733. Epub 2011 Jun 10. Int J Cancer. 2011. PMID: 20957629

10

Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.

Concha A, Esteban F, Cabrera T, Ruiz-Cabello F, Garrido F. Concha A, et al. Among authors: cabrera t. Semin Cancer Biol. 1991 Feb;2(1):47-54. Semin Cancer Biol. 1991. PMID: 1912518

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters